Game-changer in Spatial Biology

Lunaphore was developing an immuno­histo­chemical testing procedure that uses micro­fluidic systems to achieve faster, more precise analysis of tumor tissue. In addition, Lunaphore enabled digital pathology by inte­grating imaging systems such as a micro­scope with sequential data extraction. Lunaphore was acquired by the global life sciences company Bio-Techne Corporation (NASDAQ:TECH) in 2023.

adivo Overview Versantis